Research Site

Chambray-lès-Tours 37170

2 studies enrolling now · 8 studies all time

What they study most

Dyslipidemia, ER-Positive HER2-Negative Breast Cancer, Endometrial Cancer, Heart Failure, Hypercholesterolemia, Malignant Solid Tumour, Plaque Psoriasis, Transthyretin Amyloid Cardiomyopathy

Studies at this site

• Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01) — Recruiting now
• A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer — Recruiting now
• Study of ALXN2220 Versus Placebo in Adults With ATTR-CM — Running, not enrolling
• Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk — Completed
• Registrational Study With Omecamtiv Mecarbil (AMG 423) to Treat Chronic Heart Failure With Reduced Ejection Fraction — Completed
• Open-label Extension (OLE) Study to Assess Safety and Efficacy of Evolocumab — Completed
• GLobal Assessment of Plaque reGression With a PCSK9 antibOdy as Measured by intraVascular Ultrasound — Completed
• Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis — Completed